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Background: This prospective study investigated the safety and efficacy of a therapeutic method of treating
pterygium complicated with conjunctivochalasis, using pterygium excision and conjunctival autotransplantation
combined with sclera fixation, followed by therapeutic contact lens application.
Methods: Fifty-seven patients (83 eyes) diagnosed as pterygium complicated with conjunctivochalasis, at our
hospital from July 2011 to June 2012, were selected. Patients were treated with pterygium excision and conjunctival
autotransplantation combined with sclera fixation surgery, then therapeutic bandage contact lenses were applied. The
efficacy of simultaneous surgery was evaluated based on vision changes, tear dynamics, and other complications.
Histopathological changes were investigated on removed bulbar conjunctival tissue, using hematoxylin eosin (HE) and
Masson’s trichrome staining.
Results: (1) Three months after the operation, the success of simultaneous surgery in the treatment of pterygium was
97.6 %, and the recurrence was 2.4 %. Based on subjective evaluation, the success of the simultaneous treatment
of conjunctivochalasis was 95.2 %, and failure was 4.8 %. Based on objective evaluation, the success rate was
94.0 % and the recurrence rate was 6.0 %. (2) Visual acuity of the 83 eyes was significantly improved after surgery,
and was statistically significant (X2 = 10.29, P < 0.05). (3) Three months after surgery, the height and integrity of
the tear meniscus, tear film break-up time, and chloramphenicol test results of the 83 eyes were significantly
improved and there was a statistically significant difference (X2 the height and integrity of tear meniscus = 147.24,
X2 tear film break-up time = 81.17, X2 chloramphenicol test = 17.41, P < 0.01). (4) Complications after the operation
such as granulation hyperplasia, constrictive fornix, oculomotor defect, and other complications were not observed.
(5) Pathological observations, using HE and Masson’s trichrome staining of removed bulbar conjunctival tissue, showed
several pathological changes, including obvious squamous epithelial hyperplasia, parakeratosis, basal cell pigmentation,
lamina propria hemorrhage, infiltration of lymphocytes, and reduction of elastic fibers and collagen fibers.
Conclusion: Pterygium excision and conjunctival autotransplantation, combined with sclera fixation followed by
therapeutic contact lens use was safe, effective, and suitable for simultaneous treatment of pterygium complicated
with conjunctivochalasis.
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Pterygium is a common clinical ocular surface disease,
mainly characterized by fibrovascular overgrowth of bul-
bar conjunctiva across the limbus onto the cornea, thus
affecting appearance, vision and comfort [1]. Now it was
believed that its formation and recurrence were caused
by ultraviolet light, dust, dryness, heat or other environ-
mental factors [2]. Conjunctivochalasis as a kind of ocu-
lar disease resulted from redundance of conjunctiva
epithelium or stroma in the lower forniceal conjunctiva
or the lower half of the bulbar conjunctiva, which caused
the dysfunction of tears over ocular surface [3]. Pteryg-
ium complicated with conjunctivochalasis was common
ocular surface diseases, which leaded to ocular irritation
symptoms such as dryness and tears [4]. And these dis-
eases would affect appearance, or even vision, work and
life seriously.
In this study, pterygium excision and conjunctival auto-
transplantation combined with sclera fixation followed by
therapeutic contact lens was applied to simultaneously
treat pterygium complicated with conjunctivochalasis.
The redundancy of inferior bulbar conjunctiva in the pa-
tients with conjunctivochalasis was utilized as autograft to
repair sclera wound caused by pterygium excision. This
method resumed the normal surface of eye conjunctiva
and promoted recovery of the morphology and function
of conjunctiva. Then vision changes, tear dynamics and
other complications were evaluated. Meanwhile, the re-
moved part of bulbar conjunctival tissue was investigated
based on Hematoxylin Eosin (HE) staining and Masson
Trichrome, which showed that the pathological changes
in conjunctival tissues included the obvious squamous
epithelial hyperplasia, parakeratosis, basal cell pigmenta-
tion, lamina propria hemorrhage, infiltration of lympho-
cytes, elastic fibers and reduction of collagen fibers. To
our best knowledge, although some special cases involved
in simultaneous pterygium and chalasis surgery has been
reported by another group previously in 2013 [5], it was
the first time to report comprehensive evaluation of simul-
taneous treatment of pterygium complicated with con-
junctivochalasis. This study aimed to provide the detail of
this effective method and confirmed that it was safe, ef-
fective, and suitable for simultaneous treatment of pteryg-
ium complicated with conjunctivochalasis. Now the
report was as follows.
Methods
The study was approved by the Hospital Scientific
Committee “Committee of Zhujiang Hospital of Southern
Medical University” and written informed consent was ob-
tained from all patients included in the study. 57 patients
(83 eyes) diagnosed as pterygium complicated with con-
junctivochalasis in our hospital from July, 2011 to June,
2012 were selected with an average of 70.6 ± 6.3 years old.All 83 eyes were primary nasal pterygium complicated
with different degrees of conjunctivochalasis, in which the
head of pterygium had grown into limbus corneae more
than 2 mm. Conjunctivochalasis were divided into differ-
ent stages according to the theory of Zhang et al. [6] (15
eyes with Grade-I (18.1 %), 41 eyes with grade-II (49.4 %),
23 eyes with grade- III level (27.7 %) and 4 eyes with
grade- IV (4.8 %)). Exclusion criteria: patients with sys-
temic or other partial ocular diseases such as hyperthy-
roidism, acute ocular inflammation, xerophthalmia,
lacrimal disease, high tension of lower margo palpebrae,
entropion and other ocular surface diseases.
(1) 4 g/L Hydrochloric Acid Oxybuprocaine Drops and
20 g/L Lidocaine (0.5 ml) were used for topical
anesthesia and pterygium anesthesia respectively.
(2) Under surgical microscope, the conjunctival
tissue on both sides of the neck of pterygium was
cut off, and the surface of conjunctiva on the neck
of pterygium was dissected parallel to limbus
corneae. The conjunctiva was severed from the
underlying fibrous tissue till plica semilunaris. Then
the pterygium at the point of plica semilunari was
excised, and the head of pterygium was avulsed
reversely from the point of plica semilunari to the
center of the cornea. After that, the blade was
applied to scrape the abnormal tissue remnant,
which ensured excellent polishing and smoothing of
the surface. Finally, hemostasis was achieved with
coagulation of the bare sclera. (3) The width at the
limbus, width of the nasal lesion and distance from
the limbus to the margin to be excised would be
measured to determine the size of conjunctival
autograft. Then a piece of conjunctival flap with
limbal stem cells harvested in inferior corneal limbus
was transferred to the bare sclera after the
pterygium excision. And the reflected conjunctival
flap was pressed down onto the corneal, and the
subepithelial fibers should be made sure to overlay
the sclera taut. Additionally, its limbus should be
aligned with the limbus of bare scleral bed. The
graft was then attached to the perilimibal conjunctiva
and episclera with 10–0 nylon sutures in simple
interrupted fashion. On the other hand, the excess
bulbar conjunctiva was removed according to the
relaxation degree of conjunctiva, and the bulbar
conjunctiva was sutured to inferior limbus corneae
with 10–0 nylon sutures in simple interrupted
fashion. The incision on the nasal and temporal site
was sutured in continuous manner to the episclera. At
the same time, the bulbar conjunctiva was sutured to
episclera at 6–8 cm below limbus corneae with 10–0
nylon sutures in simple interrupted fashion. When
suturing under the microscope, the angle and depth
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puncture of ocular wall. (4) After the operation, eyes
were treated with Tobramycin and Dexamethasone
Ophthalmic Ointment, and patients were proposed
to wear therapeutic corneal bandage lens. All
patients underwent a simultaneous combined
surgery; monocular operation cost 30–40 min with
no complaint of pain, less bleeding and without
abnormal complications.
From the first day after operation, Tobramycin and
Dexamethasone Ophthalmic Suspension Eye Drops were
treated 5 times per day, Pranoprofen Eye Drops were
treated 3 times per day, Sodium Hyaluronate Eye Drops
were treated 3 times per day, and FGF Eye Gel Eye
Drops were treated 3 times per day. Taper the use of eye
drops according to the healing degree of conjunctival
graft, corneal and conjunctiva, and stop using them in
2–3 months. The 10–0 nylon suture was removed
10 days after surgery and the corneal bandage lens were
removed 20 days after surgery. The removed part of the
bulbar conjunctival tissue was investigated to observe its
histopathological changes based on Hematoxylin Eosin
(HE) staining and Masson trichrome.
Patients would be paid a visit at first week, first month,
and third month respectively after the operation. The
discomforts would be asked such as eye irritation, for-
eign body sensation and epiphora. The complications
would be recorded such as conjunctival fornix shallow
and eye movement disorders, the naked visual acuity,
conjunctival flap, corneal condition, height and integrity
of Tear Meniscus, Tear Film Break-up Time, Chloram-
phenicol Test and other circumstances of the patients,
which would be compared with pre-operation followed
by making curative effect judgment.
SPSS16.0 statistical software was applied for statistical
analysis, two samples were compared by using t test,
and X2 test was used to compare rates.
Results and discussion
Criteria for pterygium: (1) Healed: free of pterygium recur-
rence and free of conjunctival congestion; (2) Effectiveness:
free of pterygium recurrence, but with conjunctival conges-
tion; (3) Ineffectiveness: pterygium recurrence. Three
months after operation, among the 83 eyes, 64 eyes wereTable 1 Three months later, the analysis of the simultaneous treatm
conjunctivochalasis
Evaluative criteria Recovery (n
pterygium objective 64 (77.1)
Conjunctivochalasis subjective 58 (69.9)
objective 62 (74.7)
n (%) the number and percentage of eyeshealed (77.1 %), 17 eyes were effective (20.5 %), 2 eyes
were ineffective (2.4 %) and the total success rate was
97.6 % (see Table 1, Fig. 1).
Criteria for conjunctivochalasis: (1) Subjective evalu-
ation on curative effect: (i) Recovery: the symptoms dis-
appeared completely; (ii) Effectiveness: with no obvious
symptoms; (iii) Ineffectiveness: there was no improve-
ment. (2) Objective evaluation on curative effect: (i) Re-
covery: there was no conjunctiva congestion in the
surgical area, and the conjunctiva attached to the scleral
surface; (ii) Effective: there was conjunctival nodular
hyperemia and scarring in surgical area; (iii) Recurrence:
conjunctiva in the surgical area was still loose and wrin-
kled. 3 months after operation, among the 83 eyes, (1)
according to subjective evaluation on curative effect, 58
eyes were recovered (69.9 %), 21 eyes were effective
(25.3 %), 4 eyes were ineffective (4.8 %) and the total
success rate was 95.2 %; (3) according to objective evalu-
ation on curative effect, 62 eyes were recovered (74.7 %),
16 eyes were effective (19.3 %), 5 eyes were ineffective
(6.0 %) and the total success rate was 94.0 % (see Table 1,
Fig. 1). Recurrent cases were all at I-II level of conjuncti-
vochalasis, which mainly featured conjunctivochalasis
accumulation in the media and lateral angle of eyes.
Criteria of the vision changes: an international visual
acuity chart was applied to compare the visual acuity of
patients before surgery with that in 3 months after sur-
gery. That improved more than 2 lines was considered
as vision improvement, that decreased more than 2 lines
was considered as visual loss and that fluctuating less
than 2 lines was considered as not significant; The visual
acuity of patients before operation ranged from 0.06 to
0.8, the median was 0.3; 3 months after surgery, the vi-
sion ranged from 0.08 to 1, the median was 0.5. Three
months after operation, the visual acuity of 56 eyes was
improved (67.5 %), and the visual acuity of 27 eyes was
not significant changed (32.5 %). The difference was sta-
tistically significant (X2 = 10.29, P <0.05, see Table 2).
Criteria of the dynamic changes of tear fluid over ocu-
lar surface: (1) the height and integrity of the tear menis-
cus: (i) Normal: more than 0.3 mm; (ii) Abnormal: less
than 0.3 or tear meniscus appeared irregular, incomplete
or interrupted. (2) Tear film break-up time (BUT): (i)
Normal: more than 10s; (ii) Abnormal: less than 10s. (3)
Chloramphenicol Test: (i) Normal: less than 10 min; (ii)ent on the patients of pterygium complicated with
(%)) Effectiveness (n (%)) Ineffectiveness (n (%))
17 (20.5) 2 (2.4)
21 (25.3) 4 (4.8)
16 (19.3) 5 (6.0)
Fig. 1 a Eye of patients before operation; b Eye of patients one month after operation
Table 3 Ocular dynamics changes of the patients before
operation and 3 months after operation
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the height and integrity of Tear Meniscus (X2 = 147.24,
P <0.01), Tear Film Break-up Time (X2 = 81.17, P <0.01),
Chloramphenicol Test (X2 = 81.17, P <0.01) were investi-
gated, the difference was statistically significant (see
Table 3).
(1) All patients have mild corneal irritation symptoms
before taking out stitches. And the symptoms would
ease following taking out stitches in 10th day after oper-
ation. (2) And 20th day after operation, the corneal ban-
dage lens would be taken out and the symptoms would
disappear basically. (3) Graft would have different de-
grees of edema within 3 days, which subsequently eased
gradually. Grafts would survive after 3 months and fused
with surrounding conjunctival tissues. (4) Three days
after operation, the dehiscence in nasal conjunctival
wound was observed in one eye with unknown reasons.
After one stitch suture with 10–0 nylon, it recovered
smoothly. (5) There were no patients with granulation
hyperplasia, subfornical constrictive or other abnormal
symptoms.
Pathological changes: HE stains and Masson trichrome
staining showed that the pathological changed in re-
moved conjunctival tissues including the obvious squa-
mous epithelial hyperplasia, parakeratosis, basal cell
pigmentation, lamina propria hemorrhage, infiltration of
lymphocytes, elastic fibers and reduction of collagen fi-
bers (see Figs. 2 and 3).
Pterydium and conjunctivochalasis were common clin-
ical ocular surface diseases. There were various methods
of pterygium surgery [7]; Mahdy and others believed
that pterygium excision combined with limbal stem cell
transplantation was the best method with the lowest re-
currence rate [8]. In this method, limbal stem cell was
mainly obtained from upper temple. In spite of theTable 2 Vision changes of the patients before operation and
3 months after operation
≤0.1 0.2 ~ 0.3 0.4 ~ 0.5 0.6 ~ 0.7 ≥0.8
Before operation 6 14 33 22 8
3 months after operation 2 5 29 33 14
By X2 test, the difference was statistically significant (X2 = 10.29, P <0.05)operation was simple, it might cause some complications
of upper conjunctiva including the formation of subcon-
junctival scarring and the stenosis, which caused un-
necessary trouble for the possible surgeries in the future,
such as cataract operation and anti-glaucoma operation
[9]. Patients with Grade II-IV conjunctivochalasis, who
were clinically ineffective to drug therapy, needed treat-
ment of surgery. The main principle was to remove the
excessive conjunctival tissue, reconstruct the ocular sur-
face, improve symptoms and appearance, and prevent
the recurrence [6, 10].
Generally, when treated of single pterygium, the super-
ior conjunctiva was used to perform pterygium surgery
with conjunctival autografting. However, as for pteryg-
ium complicated with conjunctivochalasis, the excessive
conjunctiva occurred usually inferiorly. Therefore, it was
better to excise inferior conjunctival tissue with limbal
stem cells. Amniotic membrane was the innermost layer
of the fetal membranes and the amniotic membrane
transplantation (AMT) was reported as allograft to treat
pterygium [11]. Our research applied simultaneous sur-
gery involved in autologous transplantation, which could
avoid several complications caused by allograft, such as
inflammatory response and rejection. Additionally, con-
junctival autotransplantation could relief the flabby and
accumulation parts of inferior conjunctiva, and provided
sufficient limbal stem cells and conjunctival flap to pro-
mote the healing of corneal epithelium, inhibit the
growth of fibrous tissue, reestablish barrier function of
limbus cornea and reduce relapse rate of pterygium.
And recent research showed that both pterygium and
conjunctivochalasis were associated with the decrease ofTM (n (%)) TFBT (n (%)) CT (n (%))
Before operation 0 (0.0 %) 14 (16.9 %) 22 (26.5 %)
3 months after operation 78 (94.0 %) 72 (86.7 %) 56 (67.5 %)
X2 147.24 81.17 17.41
P <0.01 <0.01 <0.01
(1) n (%) the number and percentage of normal eyes; (2) TM Tear Meniscus;
(3) TFBR Tear Film Breakup time; (4) CT Chloramphenicol Test
Fig. 2 The results of Hematoxylin Eosin (HE) staining were showed as follows; a HE X 100; b HE X 200; c HE X 400
Fig. 3 The results of Masson Trichrome were showed as follows; a Masson X 100; b Masson X 200; c Masson X 400
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bulbar conjunctiva to sclera bare area on nasal side was
for minimal excision of conjunctival tissues to save con-
junctival goblet cells as much as possible, which could
prevent further decrease of mucoprotein in tear fluid.
The utility of conjunctival autograft to repair the sclera
could resume the normal surface of eye conjunctiva and
promote recovery of the morphology and function of
conjunctiva [8, 13]. We needed to decide the amount of
excision and morphology according to the degree of
conjunctivochalasis, and trim and suture according to
the required size of conjunctival graft. We found that
the removed conjunctiva from patients with Grade III-
IV conjunctivochalasis was enough to be used as con-
junctival graft to repair the scleral wound. In case that
conjunctival graft from patients with Grade I-II conjunc-
tivochalasis was too narrow, more tension suture could
be considered.
Anti FGF topical medications was mainly applied for
invasive and recurrent pterygium, which should be limit-
edly applied for treating pterygium in clinical operation,
especially for our simultaneous treatment of pterygium
complicated with conjunctivochalasis. The reasons were
as follows: (1) Although Mitomycin C (MCC) was ap-
plied as a kind of anti FGF topical medications for pte-
rygium excision [14], it was still showed that there was
no significant difference between these patients with or
without the intraoperative application of Mitomycin C;
(2) Furthermore, some complications including irritation,
lacrimation and photophobia were more common when
simple excision was followed by MMC [15]. (3) In addition,
the operative treatment of conjunctivochalasis needed cer-
tain fibrous tissue proliferation to form scarring and pre-
vent recurrence. Therefore, the simultaneous surgery of
patients with pterygium and conjunctivochalasis should
avoid the application of anti FGF topical medications.
In addition, as Hu CX et al. [16] reported in 2006, the
total success of crescent shaped conjunctiva resection
combined with scleral fixation was 91.48 %, which was
higher than the respective success of single crescent
shaped conjunctiva resection (87.5 %) or conjunctival su-
ture fixation (75.0 %). In this research, we adopted the
method of crescent shaped conjunctiva resection com-
bined with scleral fixation. And 3 months after oper-
ation, the effectiveness rate was 94.0 %. The recurrence
rate was lower in the research, because the local inflam-
mation and scarring formation in simultaneous oper-
ation were relatively more severe and consequently the
adhesion was firmer. And this also indicated that fibrin
glue was not suitable for scleral fixation in our research.
Because the application of fibrin glue tended to make
less inflammatory than the application of suturing [17].
This research adopted the method of pterygium exci-
sion and conjunctival autotransplantation combinedwith sclera fixation followed by therapeutic contact lens
for simultaneous treatment of pterygium complicated
with conjunctivochalasis. The redundant conjunctival
tissues with rich limbal stem cells were used fully in the
simultaneous surgery [18]. The significances of simultan-
eous treatment were concluded as follows. (1) It not only
solved the problem of relaxation and accumulation of
the underlying conjunctiva but also supplied sufficient
limbal stem cells and conjunctival graft to the nasal sur-
gery area. It played roles of promoting the healing of
corneal epithelium, inhibiting the growth of fibrous tis-
sue, reconstructing the barrier function of corneal epi-
thelial and reducing the recurrence rate of pterygium.
(2) Some researches showed that pterygium and con-
junctivochalasis were related to the reduction of tear
mucoprotein [19]. And the conjunctival graft with limbal
stem cells was transplanted to the exposed area of nasal
sclera, which could protect conjunctival tissue for max-
imum, reduce the removal of conjunctival tissue and
preserve the conjunctival goblet cells as far as possible.
And it avoided continuing to reduce the tear mucopro-
tein. (3) It was reported that surgical trauma and post-
operative inflammation would lead to activation of
residues in tissue of pterygium fibroblasts and activation
of vascular cell, and then formation of fibrovascular tissue,
thus causing the recurrence of pterygium after surgery.
The simultaneous operation with autologous transplant-
ation effectively avoided more inflammation, rejection or
other complications brought by allograft or secondary sur-
gery, and could reduce the recurrence of pterygium. (4)
Simultaneous surgery was good for ocular surface recon-
struction and cosmetic result, effectively improved the ap-
pearance and comfort. In addition, simultaneous surgery
was easily accepted by patients owing to the shorter treat-
ment period, less cost and other qualities.Conclusions
As a result, the authors claimed that pterygium excision
and conjunctival autotransplantation combined with
sclera fixation followed by therapeutic contact lens was a
safe and effective option in simultaneous treatment of
pterygium complicated with conjunctivochalasis.Competing interests
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